"B7H3 (also known as CD276) is a type I transmembrane co-stimulatory/inhibitory molecule of the B7 family, which was firstly reported by Chen et al., in 2001. B7H3 is expressed in low levels in most normal cells, such as immune cells, osteoblasts, and endothelial cells, while it is overexpressed in a wide variety of malignant cells . The receptor of B7H3 is yet to be identified, so also is its role in immune regulation and inflammatory response still controversial. However, recent studies showed that it plays a regulatory role in immunosuppression. Besides its identified function in modulating immunity, B7H3 also plays a nonimmunologic role by regulating the proliferation, migration, invasion
and metabolism of various cancer cells , and in osteoblastic differentiation and bone mineralization. "